Patent · US Expired

Preventives/remedies for inflammatory airway diseases

US7214672B2 · kind B2 · utility

5Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2001
Grant dateMay 8, 2007
Priority date
Expiry dateJun 29, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J7/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A preventive and/or therapeutic agent for inflammatory respiratory tract diseases containing, as an active ingredient, a steroid derivative represented by the following formula (1):(wherein R represents a hydrogen atom, a halogen atom, a hydroxy group, or —OCOR1 (wherein R1 represents a linear or branched alkyl group which may be substituted by a halogen atom or a cycloalkyl group; a cycloalkyl group; or an aryl group)).These compounds can continuously suppress respiratory tract inflammation and respiratory tract hyperreaction and show a high site selectivity and little systemic effect when administered directly to the respiratory tract. By virtue of these characteristics, these compounds are remarkably useful in clinical medicine as highly safe preventive and/or therapeutic agents for inflammatory respiratory tract diseases which can be administered for a long period of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.